|
07/11/2024
|
07:00
|
Agreement extended with genetic medicines customer
|
RNS
|
|
06/11/2024
|
07:00
|
Commercial Trading Update
|
RNS
|
|
05/11/2024
|
07:00
|
Posting of Annual Report and Notice of AGM
|
RNS
|
|
22/10/2024
|
07:00
|
Full Year Results for the 12mths to 30 June 2024
|
RNS
|
|
17/10/2024
|
07:00
|
Notice of Results and Investor Presentation
|
RNS
|
|
16/09/2024
|
07:00
|
Director Appointment
|
RNS
|
|
03/09/2024
|
07:00
|
Aptamer extends contract with Unilever
|
RNS
|
|
27/08/2024
|
07:00
|
Block listing Interim Review
|
RNS
|
|
20/08/2024
|
14:26
|
Holding(s) in Company
|
RNS
|
|
16/08/2024
|
13:04
|
TR-1: Standard form notification of major holdings
|
RNS
|
|
14/08/2024
|
11:34
|
TR-1: Standard form notification of major holdings
|
RNS
|
|
13/08/2024
|
12:57
|
Result of General Meeting and Board Changes
|
RNS
|
|
01/08/2024
|
16:33
|
Supplementary Conditional Placing for £60,000
|
RNS
|
|
24/07/2024
|
18:11
|
Posting of Circular and Notice of General Meeting
|
RNS
|
|
24/07/2024
|
12:37
|
Fundraise to Raise £2.83 million
|
RNS
|
|
08/07/2024
|
07:05
|
Update on progress in Unilever partnership
|
RNS
|
|
08/07/2024
|
07:00
|
Trading Update
|
RNS
|
|
03/07/2024
|
07:00
|
Agreement to explore Optimer vehicles for siRNA
|
RNS
|
|
24/06/2024
|
07:00
|
New Contracts Announcement for Optimer Development
|
RNS
|
|
14/06/2024
|
07:00
|
Partnership with Microsaic Systems
|
RNS
|
|
31/05/2024
|
16:06
|
Holding(s) in Company
|
RNS
|
|
28/05/2024
|
09:05
|
Holding(s) in Company
|
RNS
|
|
23/05/2024
|
07:00
|
New contracts with top ten pharma partners
|
RNS
|
|
22/05/2024
|
07:00
|
Aptamer and Timser Partnership
|
RNS
|
|
13/05/2024
|
07:45
|
Trading Update
|
RNS
|
|
25/04/2024
|
15:45
|
Holding(s) in Company
|
RNS
|
|
24/04/2024
|
08:45
|
Holding(s) in Company
|
RNS
|
|
23/04/2024
|
14:03
|
Holding(s) in Company - REPLACEMENT
|
RNS
|
|
22/04/2024
|
16:37
|
Holding(s) in Company
|
RNS
|
|
22/04/2024
|
07:00
|
Top Pharma Company evaluates Optimer for medicine
|
RNS
|
|
18/04/2024
|
10:06
|
TR-1: Notification of major holdings
|
RNS
|
|
18/04/2024
|
07:00
|
Aptamer and Kairos Biotech partner for Optimer+
|
RNS
|
|
08/04/2024
|
07:00
|
Patent submission for Optimer® binders
|
RNS
|
|
28/03/2024
|
14:07
|
Holding(s) in Company
|
RNS
|
|
28/03/2024
|
07:00
|
Interim Results
|
RNS
|
|
22/03/2024
|
07:00
|
Notice of Interim Results & Investor Presentation
|
RNS
|
|
11/03/2024
|
07:00
|
Aptamer Progresses Partnership with Unilever
|
RNS
|
|
29/02/2024
|
07:00
|
Block Listing Interim Review
|
RNS
|
|
27/02/2024
|
07:00
|
R&D progress on new Optimer®+ platform
|
RNS
|
|
22/02/2024
|
07:00
|
Second Phase of Alzheimer's test with Neuro-Bio
|
RNS
|
|
05/02/2024
|
07:00
|
Half Year Trading Update
|
RNS
|
|
04/01/2024
|
14:39
|
Holding(s) in Company
|
RNS
|
|
15/12/2023
|
15:57
|
Results of 2023 Annual General Meeting
|
RNS
|
|
15/12/2023
|
07:00
|
AGM Statement
|
RNS
|
|
14/12/2023
|
07:00
|
Material Agreement with Genetic Medicines Company
|
RNS
|
|
20/11/2023
|
07:00
|
Posting of Annual Report and Notice of AGM
|
RNS
|
|
09/11/2023
|
07:00
|
Full year results for the 12mths ended 30 Jun 2023
|
RNS
|
|
08/11/2023
|
12:20
|
Notice of Results and Investor Presentation
|
RNS
|
|
06/11/2023
|
07:00
|
Trading Update
|
RNS
|
|
24/10/2023
|
10:16
|
Holding(s) in Company
|
RNS
|